Tilmicosin Phosphate (CAS 137330-13-3) is a semisynthetic macrolide antibiotic widely used in veterinary medicine for treating respiratory infections in cattle, swine, and poultry. As a key active pharmaceutical ingredient (API) in the animal health industry, it commands significant global demand. The global Tilmicosin Phosphate market was valued at approximately USD 776.9 million in 2025 and is projected to reach USD 1.2 billion by 2035, growing at a compound annual growth rate (CAGR) of 4.4%. This growth is driven by expanding livestock farming, rising demand for veterinary antibiotics, and advancements in animal healthcare. For suppliers and manufacturers, understanding the global buyer landscape is essential for market penetration and sustained business growth.…